United Bank (Virginia)’s Vor Biopharma VOR Stock Holding History

United Bank (Virginia)’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-765	Closed	-$11K	–	145
2025 Q1	$11K	Hold	765	–	–	﹤0.01%	136
2024 Q4	$17K	Hold	765	–	–	﹤0.01%	132
2024 Q3	$10.7K	Hold	765	–	–	﹤0.01%	142
2024 Q2	$15.3K	Buy	765 +220	+40%	+$7.12K	﹤0.01%	140
2024 Q1	$25.8K	Hold	545	–	–	﹤0.01%	144
2023 Q4	$24.5K	Buy	+545	New	+$22.5K	﹤0.01%	144

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

United Bank (Virginia)'s VOR Position: Q2 2025 in Review

United Bank (Virginia) sold out of Vor Biopharma (VOR) in Q2 2025, closing a stake of 765 shares — an estimated $11K sold.

United Bank (Virginia) first reported a position in VOR in Q4 2023 and held it in 6 quarters. The position peaked at $25.8K in Q1 2024. 35 funds tracked by Wall St. Rank hold VOR as of Q2 2025.

United Bank (Virginia) reported no remaining Vor Biopharma position as of Q2 2025 after selling out during the quarter.
United Bank (Virginia) sold 765 Vor Biopharma shares in Q2 2025, an estimated $11K.
United Bank (Virginia) first reported a position in Vor Biopharma in Q4 2023 and held it in 6 quarters.
United Bank (Virginia)'s Vor Biopharma position peaked at $25.8K in Q1 2024.
35 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2025.

Based on United Bank (Virginia)'s 13F filing for Q2 2025, filed 18 Jul 2025.